Drug Shortage Report for CETIRIZINE EXTRA STRENGTH

Last updated on 2024-01-04 History
Report ID 207328
Drug Identification Number 02517566
Brand name CETIRIZINE EXTRA STRENGTH
Common or Proper name Cetirizine Hydrochloride Tablets USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) CETIRIZINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) TABLET CAPSULE
Route of administration ORAL
Packaging size 100
ATC code R06AE
ATC description ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-10-16
Estimated end date 2023-12-31
Actual end date 2024-01-03
Shortage status Resolved
Updated date 2024-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-01-04 English Compare
v8 2023-12-30 French Compare
v7 2023-12-30 English Compare
v6 2023-12-18 French Compare
v5 2023-12-18 English Compare
v4 2023-10-18 French Compare
v3 2023-10-18 English Compare
v2 2023-10-18 French Compare
v1 2023-10-18 English Compare

Showing 1 to 9 of 9